32.39
-0.105(-0.32%)
Currency In USD
Previous Close | 32.49 |
Open | 32.42 |
Day High | 32.66 |
Day Low | 32.18 |
52-Week High | 70.13 |
52-Week Low | 32.08 |
Volume | 81,409 |
Average Volume | 1.48M |
Market Cap | 5.94B |
PE | -16.87 |
EPS | -1.92 |
Moving Average 50 Days | 40.15 |
Moving Average 200 Days | 47.8 |
Change | -0.11 |
If you invested $1000 in Legend Biotech Corporation (LEGN) since IPO date, it would be worth $875.27 as of December 30, 2024 at a share price of $32.385. Whereas If you bought $1000 worth of Legend Biotech Corporation (LEGN) shares 3 years ago, it would be worth $650.69 as of December 30, 2024 at a share price of $32.385.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Legend Biotech to Present at the 43rd Annual J.P. Morgan Healthcare Conference
GlobeNewswire Inc.
Dec 19, 2024 1:01 PM GMT
SOMERSET, N.J., Dec. 19, 2024 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, today announced that Ying Huang, Ph.D., the company’s Chief Executive Officer, will present the latest co
CARVYKTI® Significantly Improved Minimal Residual Disease Negativity Compared to Standard of Care for Patients with Relapsed or Refractory Multiple Myeloma
GlobeNewswire Inc.
Dec 10, 2024 12:35 AM GMT
89 percent of evaluable patients achieved minimal residual disease (MRD) negativity with CARVYKTI® after three-year follow-up in CARTITUDE-4 study; the majority in less than 2 monthsResults add to the overall survival (OS) benefit recently reported m
Legend Biotech to Host Investor Event During the 66th American Society of Hematology (ASH) Annual Meeting and Exposition
GlobeNewswire Inc.
Nov 07, 2024 12:30 PM GMT
SOMERSET, N.J., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, will host a live webcast event for investors on Sunday, December 8, 2024, at 8:00 p.m. PT (11:00 p.m. ET)